Small margin excision of periocular basal cell carcinoma: 5 year results

British Journal of Ophthalmology

Volumn 88, Issue 3, 2004, Pages 358-360

  Hsuan, J D ^a   Harrad, R A ^a   Potts, M J ^a   Collins, C ^a  

^a BRISTOL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN;

ADNEXA DISEASE; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAFETY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; EYELID NEOPLASMS; FACIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 1542511876     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.018531     Document Type: Article

References (19)

1. Aurora AL, Blodi FC. Lesions of the eyelid. A clinicopathologic study. Surv Ophthalmol 1970;15:94-104.
2. Urbach F. Incidence of nonmelanoma skin cancer. Dermatol Clin 1991;9:751-5.
3. Cook BE, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumours in an incidence cohort in Olmstead County, Minnesota. Ophthalmology 1999;106:746-50.
4. Doxanas MT, Green WR. Factors in the successful surgical management of basal cell carcinoma for the eyelid. Am J Ophthalmol 1981;91:726-36.
5. Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 1993;38:169-92.
6. Wilson BD, Mang TS, Stoll H, et al. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 1992;128:1597-601.
7. Beutner KR, Geisse JK, Helman D, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999;41:1002-7.
8. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340-4.
9. Anderson RL. Comment on Glatt HJ, Olsen JJ, Putterman AM. Conventional frozen sections in periocular basal-cell carcinoma: a review of 236 cases. Ophthalmic Surg 1992;23:6-9.
10. Scholda C, Collin JRO. Value of histological clearance of eyelid basal cell carcinomas. Ortbit 1990;9:3-5.
11. Chalfin J, Putterman AM. Frozen section control in the surgery of basal cell carcinoma of the eyelid. Am J Ophthalmol 1979;87:802-9.
12. Mohs FE. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 1986;104:901-9.
13. Downes RN, Walker NPJ, Collin JRO. Micrographic (Mohs') surgery in the management of periocular basal cell epitheliomas. Eye 1990;4:160-8.
14. Callahan MA, Callahan A, Monheit GD. Mohs fresh-tissue technique for periorbital skin cancer. In: Hornblass A, ed. Oculoplastic, orbital and reconstructive surgery, Vol 1: Eyelids. Baltimore: Lippincott, Williams and Wilkins, 1988:643-50.
15. David DB, Gimblett ML, Potts MJ, et al. Small margin (2 mm) excision of peri-ocular basal cell carcinoma with delayed repair. Orbit 1999;18:11-15.
16. Rakofsky SI. The adequacy of the surgical excision of basal cell carcinoma. Ann Ophthalmol 1973;5:596-600.
17. Collin JRO. Basal cell carcinoma in the eyelid region. Br J Ophthalmol 1976;60:806-9.
18. Howard GR, Nerad JA, Carter KD, et al. Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid. Am J Ophthalmol 1992;113:123-33.
19. Rapini RP. Comparison of methods for checking surgical margins. J Am Acad Dermatol 1990;23:288-94.